Charles D. Hepler

5.0k total citations · 1 hit paper
36 papers, 3.7k citations indexed

About

Charles D. Hepler is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Charles D. Hepler has authored 36 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Geriatrics and Gerontology, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Economics and Econometrics. Recurrent topics in Charles D. Hepler's work include Pharmaceutical Practices and Patient Outcomes (25 papers), Patient Safety and Medication Errors (10 papers) and Pharmaceutical studies and practices (10 papers). Charles D. Hepler is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (25 papers), Patient Safety and Medication Errors (10 papers) and Pharmaceutical studies and practices (10 papers). Charles D. Hepler collaborates with scholars based in United States, Canada and Australia. Charles D. Hepler's co-authors include Linda M. Strand, Brian C. Sauer, Almut G. Winterstein, Charles Poole, Richard Segal, Neil J. MacKinnon, Richard Segal, Hanne Herborg, J A Cantrill and Caroline Morris and has published in prestigious journals such as Social Science & Medicine, Pharmaceutical Research and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Charles D. Hepler

36 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Opportunities and responsibilities in pharmaceutical care

1990 2.2k citations Charles D. Hepler, Linda M. Strand American Journal of Health-System Pharmacy profile →

Peers

Countries citing papers authored by Charles D. Hepler

Since Specialization

Citations

This map shows the geographic impact of Charles D. Hepler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Hepler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Hepler more than expected).

Fields of papers citing papers by Charles D. Hepler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Hepler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Hepler. The network helps show where Charles D. Hepler may publish in the future.

Co-authorship network of co-authors of Charles D. Hepler

This figure shows the co-authorship network connecting the top 25 collaborators of Charles D. Hepler. A scholar is included among the top collaborators of Charles D. Hepler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles D. Hepler. Charles D. Hepler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The spinal stenosis pedometer and nutrition lifestyle intervention (SSPANLI): development and pilot 2014 ·The Spine Journal ·Christy Tomkins‐Lane, (unknown), Jill A. Parnell, (unknown), (unknown), (unknown), Philip M. Wilson, Charles D. Hepler, (unknown), Richard Hu	28
2	Application of system-level root cause analysis for drug quality and safety problems: A case study 2012 ·Research in Social and Administrative Pharmacy ·Brian C. Sauer, Charles D. Hepler	10
3	Computerized indicators of potential drug-related emergency department and hospital admissions. 2007 ·PubMed ·Brian C. Sauer, Charles D. Hepler, (unknown), (unknown)	14
4	Balancing Pharmacists’ Conscientious Objections with Their Duty to Serve 2005 ·Journal of the American Pharmacists Association ·Charles D. Hepler	11
5	A pharmacist model of perceived responsibility for drug therapy outcomes 2004 ·Social Science & Medicine ·Lourdes G. Planas, Carole L. Kimberlin, Richard Segal, David B. Brushwood, Charles D. Hepler, Barry R. Schlenker	35
6	Clinical Pharmacy, Pharmaceutical Care, and the Quality of Drug Therapy 2004 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Charles D. Hepler	113
7	Preventing Medication Errors and Improving Drug Therapy Outcomes: A Management Systems Approach 2003 ·TU Digital Collections (Thammasat University) ·Charles D. Hepler, Richard Segal	28
8	Preventing drug-related morbidity--determining valid indicators 2002 ·International Journal for Quality in Health Care ·Caroline Morris, J A Cantrill, Charles D. Hepler, (unknown)	61
9	Preventable Drug-related Morbidity in Older Adults-1. Indicator Development (Part 1 of a 2-part series) 2002 ·Journal of Managed Care Pharmacy ·Neil J. MacKinnon, Charles D. Hepler	46
10	Preventable Drug-Related Hospital Admissions 2002 ·Annals of Pharmacotherapy ·Almut G. Winterstein, Brian C. Sauer, Charles D. Hepler, Charles Poole	28
11	Improving Drug Therapy for Patients with Asthma-Part 2: Use of Antiasthma Medications 2001 ·Journal of the American Pharmaceutical Association (1996) ·Hanne Herborg, (unknown), Torben Jørgensen, (unknown), Charles D. Hepler, Helle Holst, (unknown)	45
12	Research: Improving Drug Therapy for Patients with Asthma-Part 1: Patient Outcomes 2001 ·Journal of the American Pharmaceutical Association (1996) ·Hanne Herborg, (unknown), (unknown), (unknown), Tove Jörgensen, Charles D. Hepler, (unknown), (unknown)	97
13	Regulating for Outcomes as a Systems Response to the Problem of Drug-Related Morbidity 2001 ·Journal of the American Pharmaceutical Association (1996) ·Charles D. Hepler	15
14	The Pharmacists' Implementation of Pharmaceutical Care (PIPC) Model 1997 ·Pharmaceutical Research ·Folakemi T. Odedina, Charles D. Hepler, Richard Segal, (unknown)	45
15	Looking Toward a Market for Pharmaceutical Care 1997 ·Journal of the American Pharmaceutical Association (1996) ·Charles D. Hepler	6
16	Issues in Implementing Pharmaceutical Care 1993 ·American Journal of Health-System Pharmacy ·Charles D. Hepler	10
17	The Future of Pharmacy: Pharmaceutical Care 1990 ·American Pharmacy ·Charles D. Hepler	37
18	Clozapine and theOutmoded Drug Use Process 1990 ·American Pharmacy ·Charles D. Hepler	4
19	Opportunities and Responsibilities in Pharmaceutical Care 1989 ·American Journal of Pharmaceutical Education ·Charles D. Hepler, Linda M. Strand	403
20	Use of simulation to develop multiple-dose regimens for drugs exhibiting nonlinear elimination kinetics 1980 ·American Journal of Health-System Pharmacy ·Charles D. Hepler, Randall A. Prince	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact